Chemotherapy negatively impacts the tumor immune microenvironment in NSCLC: an analysis of pre- and post-treatment biopsies in the multi-center SAKK19/09 study

BACKGROUND: Over the past few years, immune checkpoint inhibitors have changed the therapeutic landscape of non-small-cell lung cancer (NSCLC). Response to immune checkpoint inhibitors correlates with a pre-existing anti-tumoral immune response. Checkpoint inhibitors have been introduced as second-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Amrein, M. A., Bührer, E. D., Amrein, M. L., Li, Q., Rothschild, S., Riether, C., Jaggi, R., Savic-Prince, S., Bubendorf, L., Gautschi, O., Ochsenbein, A. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889678/
https://www.ncbi.nlm.nih.gov/pubmed/32767058
http://dx.doi.org/10.1007/s00262-020-02688-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889678/
https://www.ncbi.nlm.nih.gov/pubmed/32767058
http://dx.doi.org/10.1007/s00262-020-02688-4

Ejemplares similares